Previous 10 | Next 10 |
Kahn Brothers’ 13F portfolio value increased from $646M to $698M this quarter. BP plc and Pfizer were increased, while decreasing Nam Tai Property and BlackBerry during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~...
Image source: The Motley Fool. ViewRay, Inc. (NASDAQ: VRAY) Q2 2021 Earnings Call Aug 05, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ViewRay, Inc. (VRAY) Q2 2021 Earnings Call Transcript
ViewRay Reports Second Quarter 2021 Results PR Newswire CLEVELAND , Aug. 5, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the second quarter ended June 30, 2021 . Second Quarter 2021 Highlig...
ViewRay Announces Conference Call for Second Quarter 2021 Financial Results to be Held After Market on August 5, 2021 PR Newswire CLEVELAND , July 15, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second ...
ViewRay (VRAY) announces that the Miami Cancer Institute has enrolled the first patients in its "Stereotactic MRI-guided Adaptive Radiation Therapy ((SMART)) in One Fraction for Inoperable Primary or Metastatic Carcinoma" clinical study – referred to as the SMART ONE trial.This single-...
Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial Investigator-Led Study Explores Feasibility and Tolerability of Single-fraction Stereotactic Ablative Body Radiot...
CIPhotos/iStock via Getty Images Yesterday, ViewRay ([[VRAY]] +1.6%) announced that GenesisCare, the largest provider of cancer services globally, has entered into a purchase agreement with the company for up to 14 MRIdian MR-Guided Therapy Systems enabling its expansion in the U.K. and ...
Thursday was a fine day for radiation therapy device maker ViewRay (NASDAQ: VRAY) and its shareholders. The company announced a new supply deal that sent its stock price nearly 12% higher. ViewRay and Australian privately-held oncology and cardiac healthcare services company...
GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems Canada NewsWire Master agreement includes program plans for up to a further 14 systems with immediate expansion in 2 key markets CLEVELAND , June ...
Cancer Patients Across the U.S. to Benefit from GenesisCare's Partnership with ViewRay, Inc. Leading Oncology Provider Adds MRIdian® MR-Guided Therapy Systems to the U.S. PR Newswire FORT MYERS, Fla. , June 24, 2021 /PRNewswire/ -- GenesisCare ȁ...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...